Patent Term Extended Under 35 U.S.C. 156(e)(2)

  A second interim extension of the term of U.S. Patent No. Re. 30,633 has
been granted under 35 U.S.C. 156(e)(2) for a period of one year from the
first extended expiration date of the patent. On May 16, 1994, a first
interim extension was granted under 35 U.S.C. 156(e)(2) extending the term
of the patent for a period of one year. See 1163 OG 12. The first extended
term of the patent expires on April 19, 1995. An application for patent
term extension was filed by the patent owner of record The Board of
Trustees of the University of Illinois based on approval of the product
"DEMADEX" by the Food and Drug Administration. The initial PTO review of
the application to date indicates that the `633 patent would be eligible
for a maximum five-year extension of the patent term under 35 U.S.C.